Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products Availability

Dáil Éireann Debate, Wednesday - 6 March 2019

Wednesday, 6 March 2019

Ceisteanna (206)

Stephen Donnelly

Ceist:

206. Deputy Stephen S. Donnelly asked the Minister for Health if a detailed analysis of the decision not to make Spinraza available to persons here will be provided including but not limited to the final agreed costs to the HSE and the final agreed costs in all other relevant jurisdictions; if the costs for Ireland are broadly comparable to all other jurisdictions in which Spinraza is being made available; the rationale for it not being made available here; and if he will make a statement on the matter. [11180/19]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Barr
Roinn